相似文献
1
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors.
Front Oncol. 2018 May 28;8:181. doi: 10.3389/fonc.2018.00181. eCollection 2018.
2
Hepatobiliary surgeons meet immunologists: the case of colorectal liver metastases patients.
Hepatobiliary Surg Nutr. 2019 Aug;8(4):370-377. doi: 10.21037/hbsn.2019.03.06.
3
Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.
Ann Surg Oncol. 2010 Jun;17(6):1555-63. doi: 10.1245/s10434-009-0897-3. Epub 2010 Jan 13.
4
Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases?
Dig Liver Dis. 2018 Oct;50(10):1088-1092. doi: 10.1016/j.dld.2018.06.019. Epub 2018 Jun 30.
5
Is complete liver resection without resection of synchronous lung metastases justified?
Ann Surg Oncol. 2015 May;22(5):1585-92. doi: 10.1245/s10434-014-4207-3. Epub 2014 Nov 6.
6
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases.
Ann Coloproctol. 2016 Jun;32(3):92-100. doi: 10.3393/ac.2016.32.3.92. Epub 2016 Jun 30.
7
[Liver surgery for colorectal liver metastases].
Rozhl Chir. 2018 Spring;97(4):149-155.
8
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
Eur J Surg Oncol. 2013 Sep;39(9):981-7. doi: 10.1016/j.ejso.2013.06.009. Epub 2013 Jul 8.
9
[Colorectal liver metastases surgery - the present and the perspectives].
Rozhl Chir. 2014 Dec;93(12):568-71.
10
Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.
Dig Dis. 2018;36(6):437-445. doi: 10.1159/000490411. Epub 2018 Jul 3.
引用本文的文献
1
Ranking as a Procedure for Selecting a Replacement Variable in the Score Predicting the Survival of Patients Treated with Curative Intent for Colorectal Liver Metastases.
Medicina (Kaunas). 2023 Nov 15;59(11):2003. doi: 10.3390/medicina59112003.
2
Multimodality liver directed treatment for colorectal liver metastasis: Array of complementary options can improve outcomes - A single centre experience from India.
Front Oncol. 2023 Mar 22;13:1073311. doi: 10.3389/fonc.2023.1073311. eCollection 2023.
3
Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool.
J Pers Med. 2021 Oct 21;11(11):1059. doi: 10.3390/jpm11111059.
4
Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases.
Cancers (Basel). 2021 Mar 3;13(5):1075. doi: 10.3390/cancers13051075.
5
Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis.
Int J Hepatol. 2020 Dec 17;2020:8836922. doi: 10.1155/2020/8836922. eCollection 2020.
6
ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
Sci Rep. 2020 Apr 3;10(1):5892. doi: 10.1038/s41598-020-62502-0.
7
Macrophages in Colorectal Cancer Liver Metastases.
Cancers (Basel). 2019 May 7;11(5):633. doi: 10.3390/cancers11050633.
8
Systematic Review of the Prognostic Role of the Immune System After Surgery of Colorectal Liver Metastases.
Front Oncol. 2019 Mar 19;9:148. doi: 10.3389/fonc.2019.00148. eCollection 2019.
9
Contribution of IL-33 to the Pathogenesis of Colorectal Cancer.
Front Oncol. 2018 Nov 28;8:561. doi: 10.3389/fonc.2018.00561. eCollection 2018.
本文引用的文献
1
Depleted polymorphonuclear leukocytes in human metastatic liver reflect an altered immune microenvironment associated with recurrent metastasis.
Cancer Immunol Immunother. 2018 Jul;67(7):1041-1052. doi: 10.1007/s00262-018-2149-5. Epub 2018 Mar 23.
2
Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival.
J Gastrointest Surg. 2017 Aug;21(8):1226-1236. doi: 10.1007/s11605-017-3446-6. Epub 2017 May 23.
3
Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
Ann Surg. 2018 Mar;267(3):514-520. doi: 10.1097/SLA.0000000000002087.
4
Liver immunology and its role in inflammation and homeostasis.
Cell Mol Immunol. 2016 May;13(3):267-76. doi: 10.1038/cmi.2016.3. Epub 2016 Apr 11.
5
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
Immunity. 2016 Mar 15;44(3):698-711. doi: 10.1016/j.immuni.2016.02.025.
6
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Trends Immunol. 2016 Mar;37(3):208-220. doi: 10.1016/j.it.2016.01.004. Epub 2016 Feb 6.
7
Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis.
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E874-83. doi: 10.1073/pnas.1521359113. Epub 2016 Feb 1.
8
Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort.
Ann Surg Oncol. 2016 Apr;23(4):1352-60. doi: 10.1245/s10434-015-5009-y. Epub 2015 Dec 29.
9
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.
J Autoimmun. 2016 Jan;66:40-50. doi: 10.1016/j.jaut.2015.08.011. Epub 2015 Aug 30.
10
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.
J Clin Invest. 2015 Sep;125(9):3356-64. doi: 10.1172/JCI80005. Epub 2015 Jul 13.
Zotero 插件